Explore evidence

0 %The sensitivity of the WHO symptom screen for tuberculosis was 0% among people living with HIV receiving antiretroviral therapy in western Kenya.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 12 observations

1 %Among HIV-negative tuberculosis patients in Western Kenya, STY + ETO polyresistant strains occurred in 1% of cases.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

2.8 %Among TB patients, 2.8% were transferred out.

Kenyatuberculoseobserved 2012–2020published 2023BMC infectious diseasesPubMeddocument of 11 observations

1.3 %The prevalence of pulmonary tuberculosis at enrollment was 1.3% among 383 people living with HIV in western Kenya.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 12 observations

82 %Treatment success was 82% amongst clinically diagnosed TB patients.

Kenyatuberculosepublished 2021Scientific reportsPubMeddocument of 12 observations

4,431 individualsAmong children and adolescents living with HIV in central Kenya, 4,431 (96.4%) did not have tuberculosis symptoms.

Kenyatuberculose · VIH/sidapublished 2022AIDS research and human retrovirusesPubMeddocument of 18 observations

3.7 %Studies that screened individuals regardless of symptoms using microscopy, culture, or GeneXpert®MTB/RIF had 3.7% higher case yield than symptom screening.

Kenyatuberculosepublished 2022Tuberculosis research and treatmenteurope_pmcdocument of 8 observationsDOI 10.1155/2022/9947068

2.5 odds_ratioMalnutrition was associated with tuberculosis (odds ratio 2.5, 95% confidence interval 1.14–5.72).

Kenyatuberculosepublished 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 10 observations

85 %In the Kenyan CLHIV cohort, CRISPR-TB detected 85% of unconfirmed tuberculosis cases diagnosed by non-microbiological clinical findings.

Kenyatuberculosepublished 2022The Lancet. MicrobePubMeddocument of 6 observations

1.82 AORHIV-positive individuals had adjusted odds ratio of 1.82 for receiving an Xpert® test compared to HIV-negative individuals in Kenya in 2015.

Kenyatuberculose · VIH/sidaobserved 2015published 2018BMC infectious diseaseseurope_pmcdocument of 12 observations

41 %The pooled prevalence of persistent respiratory symptoms among individuals who completed treatment for pulmonary TB in low- and middle-income countries was 41.0%.

Kenyapersistent respiratory symptoms · post-TB lung disease · tuberculosepublished 2022PLOS global public healtheurope_pmcdocument of 11 observationsDOI 10.1371/journal.pgph.0000805

23.6 %Resistance to isoniazid (INH) among HIV-positive tuberculosis patients in Western Kenya was 23.6%.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

1.1 %Aspergillus terreus, Aspergillus flavus, Aspergillus candidus, and Aspergillus clavatus were each isolated from 1 out of 88 fungal-positive sputum samples (1.1%) among PTB patients in Kenya.

Kenyatuberculosepublished 2022BMC infectious diseasesPubMeddocument of 14 observations

4 casesAmong 65 HIV-positive patients who provided saliva samples, 4 had co-infection of Candida species and TB.

Kenyatuberculoseobserved 2003published 2006East African Medical JournalOpenAlexdocument of 8 observations

13.3 %Mycobacterium tuberculosis accounted for 13.3% of isolates.

Kenyatuberculosepublished 2023Ethiopian journal of health sciencesPubMeddocument of 9 observations

4.78 aHRAmong patients switching to dolutegravir-containing regimens, those without a recent viral load test or with a preswitch viral load ≥1000 copies/mL had an adjusted hazard ratio of 4.78 for pulmonary tuberculosis or a WHO clinical stage 4 event compared to those with preswitch viral load <200 copies/mL.

Kenyatuberculose · WHO clinical stage 4 eventpublished 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 6 observations

83 %CRISPR-TB identified microbiologically and clinically confirmed tuberculosis cases in the paediatric cohort with 83% sensitivity and 95% specificity.

Kenyatuberculosepublished 2022The Lancet. MicrobePubMeddocument of 6 observations

31.3 %About a third (31.3%) of tuberculosis cases in children required three or more facility visits before diagnosis in Gem Sub County, Siaya County, Kenya.

Kenyatuberculosepublished 2026PloS onePubMeddocument of 9 observations

13.97 aHRAmong patients switching to dolutegravir-containing regimens, those with a preswitch viral load ≥1000 copies/mL had an adjusted hazard ratio of 13.97 for pulmonary tuberculosis or a WHO clinical stage 4 event compared to those with preswitch viral load <200 copies/mL.

Kenyatuberculose · WHO clinical stage 4 eventpublished 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 6 observations

6.6 odds_ratioElevated high-sensitivity C-reactive protein was associated with tuberculosis (odds ratio 6.6, 95% confidence interval 3.87–11.52).

Kenyatuberculosepublished 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 10 observations

0.7 %Among HIV-negative tuberculosis patients in Western Kenya, INH + CAP polyresistant strains occurred in 0.7% of cases.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

17 %Among 65 HIV-positive patients who provided saliva samples, 11 (17%) were TB smear positive.

Kenyatuberculoseobserved 2003published 2006East African Medical JournalOpenAlexdocument of 8 observations

85.3 %GeneXpert detected Mycobacterium tuberculosis with a sensitivity of 85.3% (95% CI: 77.3–93.3%) in mucoid sputum specimens.

Kenyatuberculosepublished 2014African Journal of Health SciencesOpenAlexdocument of 13 observations

7.6 %Prior testing for tuberculosis was reported by 51 (7.6%) participants.

Kenyatuberculosepublished 2021BMC public healthPubMeddocument of 8 observations

-0.81 z-scoreThe tuberculosis–antiretroviral therapy group had weight-for-age z-score of -0.81 (95% CI: -1.23 to -0.38) over 6-month follow-up.

Kenyatuberculose · VIH/sidapublished 2024AIDS (London, England)PubMeddocument of 5 observations